[태그:] CognitiveDecline, HEALTH, Donanemab, AlzheimersTreatment, LillyPharmaceuticals

Lilly Pharmaceuticals Announces 35% Cognitive Decline Reduction with Experimental Alzheimer’s Drug Lilly Pharmaceuticals Announces Major Breakthrough in Alzheimer’s Treatment Lilly Pharmaceuticals has announced a major